Miromatrix
Mr. Mesquita brings over 25 years of operational experience spanning large pharma and small biotech companies. He began his career at Merck & Co, Inc. in vaccine process development. During his tenure there, Mr. Mesquita took on roles of increasing complexity within Technical Operations and Engineering, supporting the build out of new facilities and launch of novel monoclonal antibodies and other therapeutic proteins in the US and EU. Mr. Mesquita also held operational, corporate excellence, and QA roles with Amgen and Genzyme. Most recently, he was General Manager at a Mallinckrodt facility which manufactures engineered skin tissues, and VP of Operations and Program Management at Revelar, a startup company focusing on antibody development and commercialization. Mr. Mesquita has a Lean Six Sigma Green Belt certification from Merck and a Project Management Professional certification from the Project Management Institute. He holds a degree in Chemical Engineering from Rensselaer School of Engineering.
This person is not in any teams
This person is not in any offices
Miromatrix
Miromatrix is a biotechnology company engaged in the development of fully biological human organs to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization/recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care.